Latest news
Samsung Bioepis launches OPUVIZ pre-filled syringe biosimilar across Europe - Indian Pharma PostIndian Pharma Post · Mon, 10 Aug 2026 13:26:43 GMTSamsung Bioepis Launches OPUVIZ™ (Aflibercept) 40 mg/mL Pre-filled Syringe Across Europe - businesskorea.co.krbusinesskorea.co.kr · Mon, 10 Aug 2026 06:15:19 GMTSamsung Bioepis battles Janssen, Pfizer, Novartis in global biosimilar suits - CHOSUNBIZ - ChosunbizChosunbiz · Mon, 10 Aug 2026 00:42:00 GMT